Cargando…
AIM2 deletion enhances blood‐brain barrier integrity in experimental ischemic stroke
AIMS: Ischemic stroke is a life‐threatening disease with limited therapeutic strategies. Blood‐brain barrier (BBB) disruption is a critical pathological process that contributes to poor outcomes in ischemic stroke. We previously showed that the microglial inhibition of the inflammasome sensor absent...
Autores principales: | Xu, Si‐yi, Bian, Hui‐jie, Shu, Shu, Xia, Sheng‐nan, Gu, Yue, Zhang, Mei‐juan, Xu, Yun, Cao, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446221/ https://www.ncbi.nlm.nih.gov/pubmed/34156153 http://dx.doi.org/10.1111/cns.13699 |
Ejemplares similares
-
TMEM16A Inhibition Preserves Blood–Brain Barrier Integrity After Ischemic Stroke
por: Liu, Pin-yi, et al.
Publicado: (2019) -
Poncirin suppresses lipopolysaccharide (LPS)-induced microglial inflammation and ameliorates brain ischemic injury in experimental stroke in mice
por: Yang, Li-Xuan, et al.
Publicado: (2020) -
QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparation
por: Xu, Si-Yi, et al.
Publicado: (2023) -
γ-Glutamylcysteine Alleviates Ischemic Stroke-Induced Neuronal Apoptosis by Inhibiting ROS-Mediated Endoplasmic Reticulum Stress
por: Li, Hui-qin, et al.
Publicado: (2021) -
Beneficial Role of Rosuvastatin in Blood–Brain Barrier Damage Following Experimental Ischemic Stroke
por: Lu, Dan, et al.
Publicado: (2018)